Molecule Holdings Inc.

EVRRFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$626130

P/E Ratio—

52W High$0.0025

52W Low$0.0025

Avg Volume11K

Open$0.00

Beta-0.45

Earnings Financials Revenue

Molecule Holdings Inc. (EVRRF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EVRRF · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2023Report Date: Oct 23, 2023

EPS Actual

-$0.01

Revenue

$0.00B

Fiscal Period

Q4 FY2023

FY ends December

Report Date

Oct 23, 2023

After Market Close

EVRRF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2025	May 15, 2025	—	—	—	—	—	—
◌ Q2 FY2025	Apr 29, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Jan 29, 2025	—	—	—	—	—	—
◌ Q3 FY2024	Aug 30, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Jul 29, 2024	—	—	—	—	—	—
◌ Q2 FY2024	Apr 5, 2024	—	—	—	—	—	—
◌ Q4 FY2023	Dec 28, 2023	—	—	—	—	—	—
— Q4 FY2023	Oct 23, 2023	—	-$0.01	—	$0.00B	—	—

Q2 FY2025

May 15, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

Apr 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Jan 29, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 30, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Jul 29, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Apr 5, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Dec 28, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Oct 23, 2023

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for EVRRF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2023	Oct 23, 2023	—	$0.00	—	—
— Q2 FY2023	Jun 30, 2023	—	$0.01	$0.00	-70.59%
— Q2 FY2023	May 15, 2023	—	$0.01	$0.01	+0.00%
— Q4 FY2022	Oct 31, 2022	—	$0.02	$0.02	+0.00%
— Q3 FY2022	Sep 29, 2022	—	$0.02	$0.02	+0.00%

Q4 FY2023—

Report Date

Oct 23, 2023

EPS Beat/Miss

—

Price Before

$0.00

Price After

—

Q2 FY2023-70.59%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.00

Q2 FY2023+0.00%

Report Date

May 15, 2023

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q4 FY2022+0.00%

Report Date

Oct 31, 2022

EPS Beat/Miss

—

Price Before

$0.02

Price After

$0.02

Q3 FY2022+0.00%

Report Date

Sep 29, 2022

EPS Beat/Miss

—

Price Before

$0.02

Price After

$0.02

Beat Rate0 / 5 quarters

Largest Move-70.59% (Q2 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Molecule Holdings Inc. (EVRRF) most recently reported earnings on October 23, 2023 for Q4 FY2023, posting EPS of $-0.01 (in line with the analyst consensus of —). The next EVRRF earnings date is expected around September 1, 2026.

Each quarter, investors track EVRRF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EVRRF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

EVRRF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

EVRRF earnings · 4 questions

Molecule Holdings Inc.'s next earnings report is expected around September 1, 2026. EVRRF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EVRRF historically reports after market close (AMC).

EVRRF earnings datewhen is EVRRF earningsEVRRF next earnings datewhen does EVRRF report earningsEVRRF earnings calendar

▸ Source: FMP · Molecule Holdings Inc. SEC filings · US GAAP · Molecule Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026